The Duke Human Vaccine Institute's Pandemic Preparedness programs seek to build upon our world-class expertise in pandemic preparedness training, virology, immunology and CGMP manufacturing to strengthen our national response to future pandemic emergencies. We are taking a holistic approach to include pandemic preparedness training to improve and provide occupational training to those who may be exposed to infectious diseases and rapid development of pathogen-specific countermeasures to be deployed in a pandemic emergency. The DHVI Pandemic Preparedness programs include the Duke DARPA Pandemic Prevent Platform (P3) program and the Duke Infectious Diseases Response Training (DIDRT) .
In response to the anthrax attacks of 2001, the NIAID/NIH funded construction of 12 Regional Biocontainment Laboratories (RBLs) with two mandates:
- Provide state-of-the-art containment space to support research on drugs, diagnostics and vaccines against biological threats and emerging infections
- Support local and national responses to infectious disease emergencies.
RBLs were strategically constructed at major academic medical centers to create a broad research and response-training network. The Duke RBL facility in the DHVI is the home of the two Pandemic Preparedness programs: DIDRT and P3.
Related News
Our Best Shot - DHVI Documentary
The Duke Human Vaccine Institute (DHVI) was featured in a WRAL-TV documentary about the coronavirus pandemic and DHVI’s efforts to combat it.
The Duke CIVICs investigators featured in the documentary include Dr. Tom Denny, Dr. Tony Moody, and Dr. Greg Sempowski. Learn more about DHVI and its efforts to develop a coronavirus vaccine.
VIDEO: What is considered good vaccine efficacy?
